About Q Bio
Q.bio specializes in preventive medicine by detecting early signs of disease before symptoms occur, which allows for timely interventions. Their main product, the Q Exam, collects health data from various sources and stores it in a personalized BioVault, accessible through a telemedicine-friendly Q Dashboard. Unlike competitors, Q.bio offers a comprehensive health assessment and a subscription model for continuous monitoring, empowering clients to manage their health proactively. The company's goal is to transform healthcare by providing detailed insights that facilitate early disease detection.
San Carlos, CaliforniaHeadquarters
2015Year Founded
$65.2MTotal Funding
LATE_VCCompany Stage
HealthcareIndustries
11-50Employees
Risks
TFM technology may face slow adoption due to entrenched traditional MRI systems.
Reliance on venture capital funding poses financial risks if future rounds falter.
Intensifying competition in preventive healthcare could impact Q Bio's market share.
Differentiation
Q Bio's Tensor Field Mapping offers quantitative data, unlike traditional qualitative MRIs.
The Q Exam provides a comprehensive health assessment in just one hour.
Q Bio's BioVault ensures secure storage of personal health data.
Upsides
AI integration in MRI technology complements Q Bio's Tensor Field Mapping.
The rise of personalized medicine boosts demand for Q Bio's health assessments.
Telemedicine integration aligns with Q Bio's subscription model for regular assessments.
Funding
Total raised$65.17 M
Latest valuation$200.00 M
StageLATE_VC
$27
$200.00 MSERIES B
2/29/2020$40
$200.00 M